Next article Search Articles Instructions for authors  Access Statistics | Citation Manager  
REVIEW ARTICLE  

 Article Access Statistics
    Viewed7691    
    Printed295    
    Emailed8    
    PDF Downloaded863    
    Comments [Add]    
    Cited by others 2    

Recommend this journal


Click on image for details.

 Vasopressin in the pediatric cardiac intensive care unit: Myth or reality

Vishal K Singh1, Rajesh Sharma1, Amit Agrawal1, Amit Varma2
1 Escorts Heart Institute and Research Center, Okhla Road, New Delhi, India
2 Fortis & Escorts Heart Institute and Research Center Limited, Okhla Road, New Delhi, India

Correspondence Address:
Amit Varma
Fortis and Escorts Heart Institute and Research Center Limited, Okhla Road, New Delhi - 110 025
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-2069.52814

Rights and Permissions

Year : 2009  |  Volume : 2  |  Issue : 1  |  Page : 65-73

 
SEARCH
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles

  Article in PDF (375 KB)
Email article
Print Article
Add to My List
Pediatric cardiac surgery is undergoing a metamorphosis, with more and more critical patients being operated in our country today. Although the principles of physiology have not changed, it is imperative that care providers continue to stay abreast with developments and newer drugs that may help modify the outcome. The team dynamics have also become more complex, which necessitates the need for all care providers (surgeons, cardiologists, anesthesiologists, and intensivists) to better understand the interactions and benefits of newer drugs. Vasopressin has been used in our adult patients for more than a decade and recently has found its rightful place in the pediatric armoury. The objective of this article is to review the physiology of vasopressin and the rationale of its use in critically ill children with shock, in context of the available published data.






[FULL TEXT] [PDF]*
 

 

 Whats new | Sitemap | Feedback | Copyright and Disclaimer
 © 2008 Annals of Pediatric Cardiology | Published by Wolters Kluwer - Medknow
 Online since 20th April, 2008

 

 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 
 
 Reader Comments
 Email Alert *
  *
 * Requires registration (Free)
 
 REVIEW ARTICLE
 



Vishal K Singh1, Rajesh Sharma1, Amit Agrawal1, Amit Varma2
1 Escorts Heart Institute and Research Center, Okhla Road, New Delhi, India
2 Fortis & Escorts Heart Institute and Research Center Limited, Okhla Road, New Delhi, India

Correspondence Address:
Amit Varma
Fortis and Escorts Heart Institute and Research Center Limited, Okhla Road, New Delhi - 110 025
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-2069.52814

Rights and Permissions

Pediatric cardiac surgery is undergoing a metamorphosis, with more and more critical patients being operated in our country today. Although the principles of physiology have not changed, it is imperative that care providers continue to stay abreast with developments and newer drugs that may help modify the outcome. The team dynamics have also become more complex, which necessitates the need for all care providers (surgeons, cardiologists, anesthesiologists, and intensivists) to better understand the interactions and benefits of newer drugs. Vasopressin has been used in our adult patients for more than a decade and recently has found its rightful place in the pediatric armoury. The objective of this article is to review the physiology of vasopressin and the rationale of its use in critically ill children with shock, in context of the available published data.






[FULL TEXT] [PDF]*


        
Print this article     Email this article  

 Whats new | Sitemap | Feedback | Copyright and Disclaimer
 © 2008 Annals of Pediatric Cardiology | Published by Wolters Kluwer - Medknow
 Online since 20th April, 2008